Form 8-K - Current report:
SEC Accession No. 0001099910-24-000383
Filing Date
2024-11-22
Accepted
2024-11-22 08:35:36
Documents
13
Period of Report
2024-11-15
Items
Item 1.03: Bankruptcy or Receivership
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT seel_8k.htm   iXBRL 8-K 35211
  Complete submission text file 0001099910-24-000383.txt   208456

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE seel-20241115.xsd EX-101.SCH 3003
3 XBRL LABEL FILE seel-20241115_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE seel-20241115_pre.xml EX-101.PRE 22351
15 EXTRACTED XBRL INSTANCE DOCUMENT seel_8k_htm.xml XML 3666
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22245 | Film No.: 241486614
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)